Cyclotron Market Worth USD 359.8 Million by 2030 Growing at 5.1% CAGR – Reports and Data
According to a latest report by Reports and Data, the cyclotron market size is expected to reach USD 359.8 million in 2030 and register a revenue CAGR of 5.1%
NEW YORK CITY, NY, UNITED STATES, June 20, 2022 /EINPresswire.com/ — According to a latest report by Reports and Data, the cyclotron market size is expected to reach USD 359.8 million in 2030 and register a revenue CAGR of 5.1 % over the forecast period. Increasing prevalence of cancer and rising demand for radiopharmaceuticals are factors driving market revenue growth during the forecast period. In addition, increasing demand for nuclear imaging in cancer detection is further expected to drive growth of the cyclotron market.
Increasing prevalence of cancer is expected to contribute to growing demand for diagnosis and treatment of cancer. Growing incidence of cancer has led to increasing investments into research & development for development of new drugs and therapies to mitigate spread of cancer. Modern diagnostic imaging technologies, such as Positron Emission Tomography (PET), use radiopharmaceuticals to insight into tumor physiology down to molecular level. This has led to an increase in demand for nuclear imaging in cancer detection. In nuclear imaging, a radioactive tracer material is administered in body, which produces images by detecting radiation from different parts of body. The advantage of nuclear medicine imaging is that it evaluates functioning of organs and thereby helps physicians to make a diagnosis and plan treatments. This, in turn, is expected to increase demand of cyclotrons and thereby drive revenue growth of the market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/5102
Rising demand for radiopharmaceuticals has led to an increased demand for cyclotrons in manufacturing of radiopharmaceuticals. For instance, in 2018 Lutetium Lu 177 dotatate was first radioactive drug approved by USFDA to treat these rare cancers. This new drug consists of a radioactive isotope, Lu-177, attached to dotatate—a molecule that binds to GEP-NET cells that have a molecule called a somatostatin receptor on their surface. This drug then enters these somatostatin receptor−positive tumor cells and radiations emitted by Lu-177 help to kill cells, Radiopharmaceuticals known as nuclear medicine involve use of radioactive isotopes in diagnosis and treatment of cancer and cyclotrons produce radioisotopes. This is thereby expected to boost revenue growth of the market considerably.
Some Key Highlights in the Report:
The medical segment is expected to account for larger market share over the forecast period. Increasing prevalence of cancer and rising demand for radiopharmaceuticals are expected to drive revenue growth of this segment.
The 19-24 MeV segment is expected to expand at a rapid CAGR during the forecast period owing to increasing investments in scientific research and discoveries made in the field of nuclear physics. It is significant factor that is expected to boost growth of this segment.
The North America market accounted for the largest revenue share in 2021. Increasing investments in research & development of new technologies for early detection and treatment of cancer has led to increasing demand for cyclotrons and thereby driving market revenue growth. Robust presence of market players and drug manufacturers in countries of the region is further expected to propel market revenue growth.
In December 2021, Varian Medical Systems, Inc., announced an agreement with Indian Cooperative Oncology Network, to enhance access to cancer care through a value-based cancer treatment hub for the Southern Africa region. This strategic partnership includes investments in seven new linear accelerators including Halcyon and TrueBeam radiotherapy systems and associated software solutions. It is further expected to support skill development and local training of its professional staff and provide maintenance support for Varian machines.
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Cyclotron market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.
Leading companies operating in the market are:
GE Healthcare (General Electric Company), IBA Radiopharma Solutions, Sumitomo Heavy Industries, Ltd., Advanced Cyclotron Systems, Inc., Siemens Healthcare GmbH, BV Cyclotron VU, Varian Medical Systems, Inc., Ionetix Corporation, CNMC Company Inc., and PMB Alcen
To know more about the report @ https://www.reportsanddata.com/report-detail/cyclotron-market
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
Cyclotron Market Segmentation:
Application Outlook (Revenue, USD Million; 2019-2030)
Product Outlook (Revenue, USD Million; 2019-2030)
24 MeV and Above
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East & Africa
Rest of MEA
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/5102
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Get More Reports:
Surgical Imaging Market @ https://www.reportsanddata.com/report-detail/surgical-imaging-market
Infrared Imaging Market @ https://www.reportsanddata.com/report-detail/infrared-imaging-market
Colonoscopy Bowel Preparation Drugs Market @ https://www.reportsanddata.com/report-detail/colonoscopy-bowel-preparation-drugs-market
ENT Medical Devices Market @ https://www.reportsanddata.com/report-detail/ent-medical-devices-market
Cryptococcosis Market @ https://www.reportsanddata.com/report-detail/cryptococcosis-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Reports and Data
email us here
Visit us on social media: